Everolimus (RAD001) in Primary Therapy of Waldenstrom's Macroglobulinemia
This study is ongoing, but not recruiting participants.
Dana-Farber Cancer Institute
First Posted: September 14, 2009
Last Update Posted: April 17, 2017
Brigham and Women's Hospital
Information provided by (Responsible Party):
Steven P. Treon, MD, PhD, Dana-Farber Cancer Institute